- The role of APOBEC3C in modulating the tumor microenvironment and stemness properties of glioma: evidence from pancancer analysis
Shoudu Zhang et al, 2023, Frontiers in Immunology CrossRef - APOBEC3B, a molecular driver of mutagenesis in human cancers
Jun Zou et al, 2017, Cell & Bioscience CrossRef - The Identification of APOBEC3G as a Potential Prognostic Biomarker in Acute Myeloid Leukemia and a Possible Drug Target for Crotonoside
Chenchen Ma et al, 2022, Molecules CrossRef - The eQTL-missense polymorphisms of APOBEC3H are associated with lung cancer risk in a Han Chinese population
Meng Zhu et al, 2015, Scientific Reports CrossRef - A Tumor-Promoting Phorbol Ester Causes a Large Increase in APOBEC3A Expression and a Moderate Increase in APOBEC3B Expression in a Normal Human Keratinocyte Cell Line without Increasing Genomic Uracils
Sachini U. Siriwardena et al, 2019, Molecular and Cellular Biology CrossRef - APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer
Shixiang Wang et al, 2018, Oncogene CrossRef - FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis
Catherine E. Waters et al, 2015, Oncotarget CrossRef - APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition
Rémi Buisson et al, 2017, Cancer Research CrossRef - Constructing an APOBEC-related gene signature with predictive value in the overall survival and therapeutic sensitivity in lung adenocarcinoma
Yu Luo et al, 2023, Heliyon CrossRef - APOBEC3B expression in drug resistant MCF-7 breast cancer cell lines
Onder Onguru et al, 2016, Biomedicine & Pharmacotherapy CrossRef - Association between targeted somatic mutation (TSM) signatures and HGS‐OvCa progression
Robyn A. Lindley et al, 2016, Cancer Medicine CrossRef - Viral subversion of APOBEC3s: Lessons for anti-tumor immunity and tumor immunotherapy
Faezeh Borzooee et al, 2018, International Reviews of Immunology CrossRef - Evolutionary Comparative Analyses of DNA-Editing Enzymes of the Immune System: From 5-Dimensional Description of Protein Structures to Immunological Insights and Applications to Protein Engineering
Atefeh Ghorbani et al, 2021, Frontiers in Immunology CrossRef - AID/APOBEC deaminases and cancer
Stefan Rebhandl et al, 2015, Oncoscience CrossRef - Research on the influence of APOBEC family on the occurrence, diagnosis, and treatment of various tumors
Jing Yang et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef - Analysis of APOBEC3A/3B germline deletion polymorphism in breast, cervical and oral cancers from South India and its impact on miRNA regulation
Sundaramoorthy Revathidevi et al, 2016, Tumor Biology CrossRef - DNA cytosine and methylcytosine deamination by APOBEC3B: enhancing methylcytosine deamination by engineering APOBEC3B
Yang Fu et al, 2015, Biochemical Journal CrossRef - An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers
Kin Chan et al, 2015, Nature Genetics CrossRef - APOBEC3B expression in human leptomeninges and meningiomas
Mahlon D. Johnson et al, 2016, Oncology Letters CrossRef - Mutation-promoting molecular networks of uncontrolled inflammation
Hui Zhang et al, 2017, Tumor Biology CrossRef - APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential
Kelly Butler et al, 2023, Journal of Hematology & Oncology CrossRef - Evidence for APOBEC3B mRNA and protein expression in oral squamous cell carcinomas
Galinos Fanourakis et al, 2016, Experimental and Molecular Pathology CrossRef - Germline APOBEC3B deletion increases somatic hypermutation in Asian breast cancer that is associated with Her2 subtype, PIK3CA mutations and immune activation
Jia‐Wern Pan et al, 2021, International Journal of Cancer CrossRef